Current location:Index > News > Content

NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions

时间:2020-04-17 14:17:15  来源:NMPA

According to the newly revised Drug Administration Law of the People's Republic of China, drug clinical trial institutions shall be subject to record filing management in lieu of accreditation. NMPA has formulated, in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.

About the Association| Contact Us Send Message To Me

Beijing ICP 05086076

Beijing public network security equipment 110108002787 NO.

Copyright © 2013 China Pharmaceutical Packaging Association All Rights Reserved